TREATMENT
Telling smokers their "lung age" promoted successful smoking cessation
| The first 150 words of the full text of this article appear below. |
G Parkes
Dr G Parkes, The Limes Surgery, Hoddesdon, Hertfordshire, UK; parkesko@hotmail.co.uk
Does describing to patients how smoking has accelerated their age-related decline in lung function ("lung age") increase smoking cessation rates?
Design: randomised controlled trial.
Allocation: concealed.
Blinding: blinded (outcome assessors).
Follow-up period: 12 months.
Setting: 5 general practices in Hertfordshire, UK.
Patients:
561 current smokers
35 years of age (mean age 53 y, 54% women, mean 17 cigarettes/d, mean 33 pack-y of smoking). Patients receiving oxygen or with a history of lung cancer, tuberculosis, asbestosis, silicosis, bronchiectasis, or pneumonectomy were excluded.
Intervention:
all patients had spirometry at baseline to measure forced expiratory volume at 1 second (FEV1). Patients in the intervention group (n = 280) were immediately given their results verbally and graphically as "lung age" (the age of the average healthy person who has an FEV1 equal to that of the patient); patients in the control
University of New Mexico College of Nursing, Albuquerque, New Mexico, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
